Target
Nuclear receptor ROR-gamma [262-507]
Ligand
BDBM325789
Substrate
n/a
Meas. Tech.
SPA Binding Assay
IC50
93.0±n/a nM
Citation
 Duan, JDhar, TGJiang, BKarmakar, AGupta, AKLu, Z Heterocyclic sulfone RORγ modulators US Patent  US9637455 Publication Date 5/2/2017 
Target
Name:
Nuclear receptor ROR-gamma [262-507]
Synonyms:
NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (aa 262-507) | ROR-gamma (A262-S507) | RORC | RORG | RORG_HUMAN | RZRG
Type:
Enzyme Catalytic Domain
Mol. Mass.:
28605.37
Organism:
Homo sapiens (Human)
Description:
aa 262-507
Residue:
246
Sequence:
APYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS
  
Inhibitor
Name:
BDBM325789
Synonyms:
US9637455, 5
Type:
Small organic molecule
Emp. Form.:
C30H26F9NO4S
Mol. Mass.:
667.582
SMILES:
CCC(=O)N1CCC(CC1)(c1ccc(cc1)C(OCc1c(F)cccc1F)(C(F)(F)F)C(F)(F)F)S(=O)(=O)c1ccc(F)cc1
Structure:
Search PDB for entries with ligand similarity: